| # | Drug | Count |
|---|---|---|
| 0 | RISDIPLAM | 2 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 1 |
| 2 | ALIROCUMAB | 1 |
| 3 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 |
| 4 | CETIRIZINE | 1 |
| 5 | CETIRIZINE HCL | 1 |
| 6 | DOCETAXEL | 1 |
| 7 | DOCETAXEL ANHYDROUS | 1 |
| 8 | LINACLOTIDE | 1 |
| 9 | LISDEXAMFETAMINE DIMESYLATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RISDIPLAM | 2 | 0.0005 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 1 | 0.0001 |
| 2 | CETIRIZINE HCL | 1 | 0.0001 |
| 3 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 4 | ALIROCUMAB | 1 | 0.0000 |
| 5 | LINACLOTIDE | 1 | 0.0000 |
| 6 | PERTUZUMAB | 1 | 0.0000 |
| 7 | LISDEXAMFETAMINE DIMESYLATE | 1 | 0.0000 |
| 8 | DOCETAXEL | 1 | 0.0000 |
| 9 | DOCETAXEL ANHYDROUS | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |